Date published: 2025-10-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

JAKMIP3 Inhibitors

The chemical class JAKMIP3 Inhibitors refers to a group of chemicals that influence the function of the protein JAKMIP3. This influence is not direct but occurs through the modulation of the JAK-STAT signaling pathway, with which JAKMIP3 is associated. The chemicals listed above are primarily inhibitors of various Janus kinases, enzymes that are key components of the JAK-STAT pathway. By inhibiting these kinases, these compounds can alter the signaling cascade, which in turn may impact the function or interactions of JAKMIP3 within the cell.

Most of these inhibitors are small molecules designed to bind to the ATP-binding pocket of the kinase domain, which prevents phosphorylation events that are necessary for signal transduction. While these inhibitors do not bind to JAKMIP3 directly, their effects on the JAK-STAT pathway can lead to changes in the activity of many proteins involved in this pathway, potentially including JAKMIP3. These changes can influence how JAKMIP3 interacts with microtubules or other cellular structures and functions. The chemical structures of these inhibitors vary, with some being more selective for particular JAK enzymes, while others have broader activity profiles.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Ruxolitinib

941678-49-5sc-364729
sc-364729A
sc-364729A-CW
5 mg
25 mg
25 mg
$246.00
$490.00
$536.00
16
(1)

Inhibits JAK1 and JAK2, potentially altering the activity of proteins like JAKMIP3 involved in this pathway.

Baricitinib

1187594-09-7sc-364730
sc-364730A
5 mg
25 mg
$196.00
$651.00
(1)

Targets JAK1 and JAK2, could modify JAKMIP3 interaction with microtubules through altered signaling.

TG101348

936091-26-8sc-364740
sc-364740A
5 mg
25 mg
$207.00
$515.00
6
(1)

Inhibits JAK2, could affect JAKMIP3 by altering JAK-STAT signaling dynamics.

Filgotinib

1206161-97-8sc-507393
10 mg
$150.00
(0)

Selective JAK1 inhibitor, could indirectly modify JAKMIP3 function by affecting signaling pathways.

Cyt387

1056634-68-4sc-364733
sc-364733A
10 mg
50 mg
$210.00
$600.00
2
(1)

Targets JAK1, JAK2, and TYK2, potentially altering JAKMIP3 involvement in JAK-STAT signaling.

Lestaurtinib

111358-88-4sc-218657
sc-218657A
sc-218657B
1 mg
5 mg
10 mg
$270.00
$320.00
$600.00
3
(1)

Inhibits JAK2, potentially affecting JAKMIP3 through modulation of JAK-STAT signaling.